Clinical trial · Interventional
Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors
Pilot Study to Develop a Group-Based E-Health Intervention for Young Adult Cancer Survivors
NCT05048316CI-TRIAL-00065647completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Investigators will test an evidence-based behavioral intervention that is responsive to Young Adults (YA's) expressed needs and priorities
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivor | — | UNRESOLVED | — |
| Young Adult | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cognitive-Behavioral Stress Management and Health Education | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- eHealth
- description
- Weekly video conference groups led by a trained facilitator
- interventionNames
- Behavioral: Cognitive-Behavioral Stress Management and Health Education
Primary outcomes (3)
- measure
- Satisfaction assessed by study-specific survey during the intervention - Acceptability
- timeFrame
- During intervention
- description
- The intervention will be deemed acceptable if, on average, participants report satisfaction with the weekly sessions as ≥2 on a 0-4 scale.
- measure
- Satisfaction assessed by study-specific survey after the intervention - Acceptability
- timeFrame
- Immediately after the intervention
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: * 18-39 years old * Diagnosed with cancer between 18-39 years old * Cancer diagnosis was non-metastatic * Completed cancer treatment between 1 month and 5 years prior to enrollment, with the exception of ongoing hormone therapy * No documented or observable psychiatric or neurological disorders that could interfere with participation (e.g., active psychosis, active substance abuse), as identified by the referring medical team, chart review, or screening * Able to speak and read English * Able to provide informed consent Exclusion Criteria: * Metastatic disease * Continued cancer treatment * Psychiatric or neurological disorders that could interfere with study participation * Vulnerable populations will not be included
References
Publications (2)
- DERIVEDFox RS, Badger TA, Moya S, Gudenkauf LM, Nelson MA, O'Neill RM, Leete JJ, Friedman SE, Katsanis E, Victorson DE, Sanford SD, Penedo FJ, Antoni MH, Oswald LB. An HRQOL Proof-Of-Concept Analysis of the eHealth TOGETHER Intervention for Adolescent and Young Adult Cancer Survivors: A Brief Report. Psychooncology. 2025 Jul;34(7):e70234. doi: 10.1002/pon.70234. PMID 40879639
- DERIVEDOswald LB, Lyleroehr M, Gudenkauf LM, Armstrong GE, Tometich DB, Sanford SD, Loecher N, Geiss C, Rodriguez Y, Scheel KL, Nieves-Lopez A, Jim HSL, Gonzalez BD, Antoni MH, Penedo FJ, Reed D, Katsanis E, Salsman JM, Victorson D, Fox RS. Development and initial testing of TOGETHER-YA: an eHealth-delivered and group-based psychosocial intervention for young adult cancer survivors. Support Care Cancer. 2022 Dec;30(12):10067-10076. doi: 10.1007/s00520-022-07382-y. Epub 2022 Oct 14. PMID 36229547